Cerity Partners LLC Tenaya Therapeutics, Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 21,912 shares of TNYA stock, worth $10,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,912Holding current value
$10,079% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
94Shares Held
43.8MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$4.32 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$3.1 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$2.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$1.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$1.51 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $19M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...